Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease

BACKGROUND: Data are limited regarding the safety of and antibody response to the BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid vaccine in adolescents and young adults with underlying disease. METHODS: This prospective observational study enrolled p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Kensuke, Funaki, Takanori, Yamada, Masaki, Mikami, Masashi, Miyake, Kozue, Ueno, Saki, Tao, Chiaki, Myojin, Shota, Aiba, Hiroyuki, Matsui, Toshihiro, Ogimi, Chikara, Kato, Hitoshi, Miyairi, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490955/
https://www.ncbi.nlm.nih.gov/pubmed/36152928
http://dx.doi.org/10.1016/j.jiac.2022.09.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490955/
https://www.ncbi.nlm.nih.gov/pubmed/36152928
http://dx.doi.org/10.1016/j.jiac.2022.09.013

Ejemplares similares